NewSquare Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $638K | Sell |
694
-20
| -3% | -$20.3K | 0.06% | 151 |
|
|
2025
Q4 | $767K | Sell |
714
-142
| -17% | -$136K | 0.07% | 138 |
|
|
2025
Q3 | $653K | Buy |
856
+383
| +81% | +$285K | 0.04% | 148 |
|
|
2025
Q2 | $369K | Buy |
473
+123
| +35% | +$95.6K | 0.03% | 155 |
|
|
2025
Q1 | $289K | Buy |
350
+165
| +89% | +$137K | 0.02% | 165 |
|
|
2024
Q4 | $143K | Sell |
185
-5,063
| -96% | -$4.19M | 0.01% | 171 |
|
|
2024
Q3 | $4.65M | Buy |
5,248
+464
| +10% | +$417K | 0.37% | 91 |
|
|
2024
Q2 | $4.33M | Buy |
4,784
+428
| +10% | +$342K | 0.37% | 92 |
|
|
2024
Q1 | $3.39M | Buy |
4,356
+172
| +4% | +$122K | 0.3% | 96 |
|
|
2023
Q4 | $2.44M | Buy |
4,184
+194
| +5% | +$113K | 0.23% | 103 |
|
|
2023
Q3 | $2.14M | Buy |
3,990
+3,749
| +1,556% | +$1.93M | 0.23% | 98 |
|
|
2023
Q2 | $113K | Buy |
241
+104
| +76% | +$43.6K | 0.01% | 168 |
|
|
2023
Q1 | $47K | Sell |
137
-1,312
| -91% | -$442K | 0.01% | 195 |
|
|
2022
Q4 | $530K | Buy |
1,449
+1,434
| +9,560% | +$508K | 0.07% | 132 |
|
|
2022
Q3 | $5K | Buy |
+15
| New | +$4.75K | ﹤0.01% | 304 |
|
|
2022
Q1 | – | Sell |
-111
| Closed | -$31K | – | 427 |
|
|
2021
Q4 | $31K | Hold |
111
| – | – | ﹤0.01% | 217 |
|
|
2021
Q3 | $26K | Hold |
111
| – | – | ﹤0.01% | 222 |
|
|
2021
Q2 | $25K | Buy |
111
+64
| +136% | +$12.9K | ﹤0.01% | 220 |
|
|
2021
Q1 | $9K | Sell |
47
-15
| -24% | -$2.93K | ﹤0.01% | 244 |
|
|
2020
Q4 | $10K | Sell |
62
-5
| -7% | -$747 | ﹤0.01% | 232 |
|
|
2020
Q3 | $10K | Sell |
67
-38
| -36% | -$5.88K | ﹤0.01% | 228 |
|
|
2020
Q2 | $17K | Hold |
105
| – | – | ﹤0.01% | 203 |
|
|
2020
Q1 | $15K | Sell |
105
-35
| -25% | -$4.81K | ﹤0.01% | 220 |
|
|
2019
Q4 | $18K | Hold |
140
| – | – | ﹤0.01% | 208 |
|
|
2019
Q3 | $16K | Hold |
140
| – | – | ﹤0.01% | 180 |
|
|
2019
Q2 | $16K | Sell |
140
-2,075
| -94% | -$244K | ﹤0.01% | 229 |
|
|
2019
Q1 | $287K | Buy |
2,215
+115
| +5% | +$14K | 0.05% | 102 |
|
|
2018
Q4 | $243K | Buy |
+2,100
| New | +$235K | 0.05% | 101 |
|
|
2018
Q1 | – | Sell |
-33
| Closed | -$3K | – | 342 |
|
|
2017
Q4 | $3K | Buy |
+33
| New | +$2.81K | ﹤0.01% | 302 |
|
|
2017
Q3 | – | Sell |
-13,376
| Closed | -$1.1M | – | 333 |
|
|
2017
Q2 | $1.1M | Buy |
13,376
+702
| +6% | +$57.3K | 0.27% | 57 |
|
|
2017
Q1 | $1.07M | Buy |
12,674
+2,085
| +20% | +$167K | 0.25% | 58 |
|
|
2016
Q4 | $779K | Buy |
10,589
+556
| +6% | +$41.4K | 0.19% | 83 |
|
|
2016
Q3 | $805K | Buy |
10,033
+505
| +5% | +$40.4K | 0.18% | 80 |
|
|
2016
Q2 | $750K | Buy |
9,528
+1,419
| +17% | +$107K | 0.18% | 76 |
|
|
2016
Q1 | $584K | Sell |
8,109
-398
| -5% | -$30.1K | 0.17% | 93 |
|
|
2015
Q4 | $717K | Buy |
8,507
+143
| +2% | +$11.9K | 0.2% | 67 |
|
|
2015
Q3 | $700K | Sell |
8,364
-355
| -4% | -$30K | 0.21% | 58 |
|
|
2015
Q2 | $728K | Buy |
8,719
+174
| +2% | +$13.3K | 0.22% | 68 |
|
|
2015
Q1 | $621K | Buy |
8,545
+387
| +5% | +$27.6K | 0.19% | 73 |
|
|
2014
Q4 | $563K | Buy |
8,158
+59
| +0.7% | +$3.98K | 0.19% | 76 |
|
|
2014
Q3 | $525K | Buy |
8,099
+719
| +10% | +$45.5K | 0.19% | 85 |
|
|
2014
Q2 | $459K | Sell |
7,380
-126
| -2% | -$7.52K | 0.16% | 87 |
|
|
2014
Q1 | $442K | Buy |
7,506
+297
| +4% | +$16.6K | 0.18% | 80 |
|
|
2013
Q4 | $368K | Buy |
7,209
+847
| +13% | +$42.4K | 0.18% | 69 |
|
|
2013
Q3 | $320K | Buy |
6,362
+226
| +4% | +$11.8K | 0.15% | 75 |
|
|
2013
Q2 | $301K | Buy |
+6,136
| New | +$334K | 0.15% | 76 |
|
Other funds holding LLY
VCM
VPM
NewSquare Capital's LLY Position: Q1 2026 in Review
NewSquare Capital reduced its Eli Lilly (LLY) stake by 2.8% in Q1 2026, selling an estimated $20.3K and leaving 694 shares worth $638K. The position accounts for 0.06% of the portfolio, ranked #151.
NewSquare Capital first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. The position peaked at $4.65M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- NewSquare Capital held 694 shares of Eli Lilly worth $638K as of Q1 2026.
- NewSquare Capital sold 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
- Eli Lilly made up 0.06% of NewSquare Capital's portfolio in Q1 2026, its #151 holding.
- NewSquare Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
- NewSquare Capital's Eli Lilly position peaked at $4.65M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on NewSquare Capital's 13F filing for Q1 2026, filed 8 May 2026.